VCYT
|Veracyte Inc
NASDAQ
USD 26.74
+0.13|+0.49%
Current Price
USD 26.74
Change
+USD 0.13 (0.49%)
P/E Ratio
65.74
Dividend Yield
Market Cap
2.16B
Volume
928,803
Open
USD 26.57
Previous Close
USD 26.61
52-Week High
USD 47.32
52-Week Low
USD 19.73
About Veracyte Inc

Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It is also developing the nCounter analysis system services. The company ...
Sector:Healthcare
Industry:Diagnostics & Research
CEO:Mr. Marc A. Stapley
Employees:824
Headquarters:South San Francisco, USA
Website:www.veracyte.com
Dividend History
Dividend Payments
Declared Date | Record Date | Payment Date | Amount | Frequency |
---|
Similar Companies
Explore Stocks by Sector
technology
finance
healthcare
Frequently Asked Questions